Blackmores Limited operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Blackmores Limited with three other
pharmaceutical manufacturers in Australasia:
sales of 2.52 million Australian Dollars [US$1.94 million]
of which 100%
was HyperImmune Products),
ECS Botanics Holdings Ltd
(919,128.00 Australian Dollars [US$708,114.59 ]
(835,908.00 Australian Dollars [US$644,000.24 ]
Blackmores Limited reported sales of A$568.35 million (US$437.87 million)
June of 2020.
decrease of 6.8%
versus 2019, when the company's sales were A$609.50 million.